nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Hydrocortisone—psoriasis	0.222	0.537	CrCtD
Danazol—Prednisone—psoriasis	0.191	0.463	CrCtD
Danazol—PGR—Betamethasone—psoriasis	0.0422	0.23	CbGbCtD
Danazol—SHBG—Hydrocortisone—psoriasis	0.0379	0.207	CbGbCtD
Danazol—PGR—Dexamethasone—psoriasis	0.0245	0.134	CbGbCtD
Danazol—CYP19A1—Betamethasone—psoriasis	0.0237	0.13	CbGbCtD
Danazol—Fluoxymesterone—Clobetasol propionate—psoriasis	0.0193	0.0692	CrCrCtD
Danazol—Prednisone—Clobetasol propionate—psoriasis	0.0188	0.0674	CrCrCtD
Danazol—CYP19A1—Dexamethasone—psoriasis	0.0138	0.0754	CbGbCtD
Danazol—Formestane—Hydrocortisone—psoriasis	0.0132	0.0473	CrCrCtD
Danazol—Levonorgestrel—Hydrocortisone—psoriasis	0.0109	0.0392	CrCrCtD
Danazol—Norethindrone—Hydrocortisone—psoriasis	0.00878	0.0315	CrCrCtD
Danazol—Cortisone acetate—Hydrocortisone—psoriasis	0.00851	0.0305	CrCrCtD
Danazol—CYP3A4—Calcitriol—psoriasis	0.00785	0.0428	CbGbCtD
Danazol—Testolactone—Betamethasone—psoriasis	0.00767	0.0275	CrCrCtD
Danazol—Testolactone—Dexamethasone—psoriasis	0.00767	0.0275	CrCrCtD
Danazol—Fluoxymesterone—Hydrocortisone—psoriasis	0.00759	0.0272	CrCrCtD
Danazol—Testolactone—Triamcinolone—psoriasis	0.00749	0.0268	CrCrCtD
Danazol—Progesterone—Hydrocortisone—psoriasis	0.00739	0.0265	CrCrCtD
Danazol—Prednisone—Hydrocortisone—psoriasis	0.00739	0.0265	CrCrCtD
Danazol—Testosterone Propionate—Hydrocortisone—psoriasis	0.00739	0.0265	CrCrCtD
Danazol—Cortisone acetate—Prednisone—psoriasis	0.00733	0.0263	CrCrCtD
Danazol—Methyltestosterone—Hydrocortisone—psoriasis	0.00721	0.0258	CrCrCtD
Danazol—Cortisone acetate—Prednisolone—psoriasis	0.00715	0.0256	CrCrCtD
Danazol—Testolactone—Prednisone—psoriasis	0.00711	0.0255	CrCrCtD
Danazol—Fluoxymesterone—Betamethasone—psoriasis	0.00705	0.0253	CrCrCtD
Danazol—Fluoxymesterone—Dexamethasone—psoriasis	0.00705	0.0253	CrCrCtD
Danazol—Testolactone—Prednisolone—psoriasis	0.00694	0.0249	CrCrCtD
Danazol—Fluoxymesterone—Triamcinolone—psoriasis	0.00688	0.0247	CrCrCtD
Danazol—Prednisone—Betamethasone—psoriasis	0.00686	0.0246	CrCrCtD
Danazol—Prednisone—Dexamethasone—psoriasis	0.00686	0.0246	CrCrCtD
Danazol—Prednisone—Triamcinolone—psoriasis	0.00671	0.024	CrCrCtD
Danazol—Testosterone—Hydrocortisone—psoriasis	0.00642	0.023	CrCrCtD
Danazol—Fluoxymesterone—Prednisolone—psoriasis	0.00638	0.0229	CrCrCtD
Danazol—Prednisone—Prednisolone—psoriasis	0.00621	0.0223	CrCrCtD
Danazol—Progesterone—Prednisolone—psoriasis	0.00621	0.0223	CrCrCtD
Danazol—Methyltestosterone—Prednisone—psoriasis	0.00621	0.0222	CrCrCtD
Danazol—CYP3A4—Methoxsalen—psoriasis	0.0061	0.0333	CbGbCtD
Danazol—Methyltestosterone—Prednisolone—psoriasis	0.00606	0.0217	CrCrCtD
Danazol—CCL2—skeletal joint—psoriasis	0.00588	0.336	CbGeAlD
Danazol—Hydrocortisone—Betamethasone—psoriasis	0.0056	0.0201	CrCrCtD
Danazol—Hydrocortisone—Dexamethasone—psoriasis	0.0056	0.0201	CrCrCtD
Danazol—Hydrocortisone—Triamcinolone—psoriasis	0.00547	0.0196	CrCrCtD
Danazol—Testosterone—Prednisolone—psoriasis	0.00539	0.0193	CrCrCtD
Danazol—Hydrocortisone—Prednisone—psoriasis	0.00519	0.0186	CrCrCtD
Danazol—Hydrocortisone—Prednisolone—psoriasis	0.00507	0.0182	CrCrCtD
Danazol—CCL2—synovial membrane of synovial joint—psoriasis	0.00447	0.255	CbGeAlD
Danazol—CYP3A4—Cholecalciferol—psoriasis	0.00404	0.0221	CbGbCtD
Danazol—CYP3A4—Triamcinolone—psoriasis	0.0035	0.0191	CbGbCtD
Danazol—CYP3A4—Mycophenolate mofetil—psoriasis	0.0035	0.0191	CbGbCtD
Danazol—CYP3A4—Betamethasone—psoriasis	0.00301	0.0164	CbGbCtD
Danazol—CYP3A4—Prednisolone—psoriasis	0.00297	0.0162	CbGbCtD
Danazol—CCL2—skin epidermis—psoriasis	0.00287	0.164	CbGeAlD
Danazol—CYP3A4—Hydrocortisone—psoriasis	0.00281	0.0154	CbGbCtD
Danazol—CYP3A4—Prednisone—psoriasis	0.0028	0.0153	CbGbCtD
Danazol—CYP3A4—Cyclosporine—psoriasis	0.00266	0.0145	CbGbCtD
Danazol—CCL2—endothelium—psoriasis	0.00208	0.119	CbGeAlD
Danazol—CYP3A4—Dexamethasone—psoriasis	0.00175	0.00955	CbGbCtD
Danazol—CCL2—skin of body—psoriasis	0.000888	0.0507	CbGeAlD
Danazol—CCL2—tendon—psoriasis	0.000676	0.0386	CbGeAlD
Danazol—AR—skin of body—psoriasis	0.000372	0.0212	CbGeAlD
Danazol—AR—tendon—psoriasis	0.000283	0.0162	CbGeAlD
Danazol—CCL2—Calcitriol—Calcipotriol—psoriasis	0.000136	0.048	CbGdCrCtD
Danazol—CCL2—AP-1 transcription factor network—JUN—psoriasis	0.000121	0.00312	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—NOS2—psoriasis	0.00012	0.0031	CbGpPWpGaD
Danazol—CCL2—Unfolded Protein Response (UPR)—CXCL8—psoriasis	0.000119	0.00308	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—TNF—psoriasis	0.000116	0.00301	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IFNG—psoriasis	0.000116	0.00301	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000116	0.003	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—VEGFA—psoriasis	0.000112	0.0029	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000111	0.00288	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—STAT3—psoriasis	0.000111	0.00287	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CCL20—psoriasis	0.000111	0.00286	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—HCAR2—psoriasis	0.00011	0.00285	CbGpPWpGaD
Danazol—CCL2—TWEAK Signaling Pathway—IL6—psoriasis	0.00011	0.00284	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HCAR2—psoriasis	0.000109	0.00282	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.000107	0.00278	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000106	0.00276	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000105	0.00271	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000105	0.0027	CbGpPWpGaD
Danazol—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000103	0.00267	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CCL20—psoriasis	0.000101	0.00262	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HCAR2—psoriasis	9.99e-05	0.00258	CbGpPWpGaD
Danazol—ESR1—Estrogen signaling pathway—JUN—psoriasis	9.96e-05	0.00258	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—JUN—psoriasis	9.7e-05	0.00251	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—NFKB1—psoriasis	9.68e-05	0.0025	CbGpPWpGaD
Danazol—AR—Nuclear Receptor transcription pathway—PPARG—psoriasis	9.64e-05	0.00249	CbGpPWpGaD
Danazol—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	9.58e-05	0.00248	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	9.55e-05	0.00247	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TNF—psoriasis	9.48e-05	0.00245	CbGpPWpGaD
Danazol—CCL2—Vitamin B12 Metabolism—IL6—psoriasis	9.4e-05	0.00243	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptors—PPARG—psoriasis	9.39e-05	0.00243	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—NFKB1—psoriasis	9.34e-05	0.00242	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	9.29e-05	0.0024	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IFNG—psoriasis	9.2e-05	0.00238	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL13—psoriasis	8.79e-05	0.00227	CbGpPWpGaD
Danazol—CCL2—Calcitriol—Cholecalciferol—psoriasis	8.76e-05	0.0309	CbGdCrCtD
Danazol—CCL2—Spinal Cord Injury—CXCL8—psoriasis	8.55e-05	0.00221	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	8.47e-05	0.00219	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—TP53—psoriasis	8.46e-05	0.00219	CbGpPWpGaD
Danazol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	8.36e-05	0.00216	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TP53—psoriasis	8.36e-05	0.00216	CbGpPWpGaD
Danazol—AR—Notch-mediated HES/HEY network—CD4—psoriasis	8.15e-05	0.00211	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—REN—psoriasis	8.15e-05	0.00211	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	8.06e-05	0.00209	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL10—psoriasis	8.04e-05	0.00208	CbGpPWpGaD
Danazol—PGR—Gene Expression—TARS—psoriasis	8.03e-05	0.00208	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—TP53—psoriasis	7.97e-05	0.00206	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	7.88e-05	0.00204	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL4—psoriasis	7.82e-05	0.00202	CbGpPWpGaD
Danazol—AR—FOXA1 transcription factor network—JUN—psoriasis	7.69e-05	0.00199	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—IL6—psoriasis	7.65e-05	0.00198	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—TNF—psoriasis	7.53e-05	0.00195	CbGpPWpGaD
Danazol—PGR—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	7.48e-05	0.00194	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	7.42e-05	0.00192	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	7.36e-05	0.0019	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—IL6—psoriasis	7.3e-05	0.00189	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—TNF—psoriasis	7.27e-05	0.00188	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	7.16e-05	0.00185	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	7.12e-05	0.00184	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	7.09e-05	0.00183	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	7.07e-05	0.00183	CbGpPWpGaD
Danazol—AR—Regulation of Androgen receptor activity—JUN—psoriasis	6.63e-05	0.00171	CbGpPWpGaD
Danazol—CCL2—Methylprednisolone—Clobetasol propionate—psoriasis	6.57e-05	0.0232	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—HCAR2—psoriasis	6.45e-05	0.00167	CbGpPWpGaD
Danazol—AR—Notch-mediated HES/HEY network—STAT3—psoriasis	6.31e-05	0.00163	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—LEP—psoriasis	6.26e-05	0.00162	CbGpPWpGaD
Danazol—AR—Gene Expression—TARS—psoriasis	6.12e-05	0.00158	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—IL6—psoriasis	6.08e-05	0.00157	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TNF—psoriasis	5.95e-05	0.00154	CbGpPWpGaD
Danazol—ESR1—FOXA1 transcription factor network—JUN—psoriasis	5.93e-05	0.00153	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HCAR2—psoriasis	5.9e-05	0.00153	CbGpPWpGaD
Danazol—CCL2—Beclomethasone—Clobetasol propionate—psoriasis	5.89e-05	0.0208	CbGdCrCtD
Danazol—CCL2—TNF alpha Signaling Pathway—IL6—psoriasis	5.86e-05	0.00152	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CXCL8—psoriasis	5.84e-05	0.00151	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CCL20—psoriasis	5.71e-05	0.00148	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CCL20—psoriasis	5.67e-05	0.00147	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TAGAP—psoriasis	5.59e-05	0.00145	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	5.56e-05	0.00144	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.51e-05	0.00142	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL10—psoriasis	5.5e-05	0.00142	CbGpPWpGaD
Danazol—Asthenia—Hydroxyurea—psoriasis	5.46e-05	0.000836	CcSEcCtD
Danazol—Weight increased—Prednisone—psoriasis	5.45e-05	0.000835	CcSEcCtD
Danazol—Hypertension—Cyclosporine—psoriasis	5.45e-05	0.000835	CcSEcCtD
Danazol—Constipation—Mycophenolic acid—psoriasis	5.45e-05	0.000834	CcSEcCtD
Danazol—Palpitations—Mycophenolate mofetil—psoriasis	5.44e-05	0.000834	CcSEcCtD
Danazol—CCL2—Fluocinonide—Clobetasol propionate—psoriasis	5.44e-05	0.0192	CbGdCrCtD
Danazol—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	5.42e-05	0.0014	CbGpPWpGaD
Danazol—Vision blurred—Prednisolone—psoriasis	5.42e-05	0.000829	CcSEcCtD
Danazol—Loss of consciousness—Mycophenolate mofetil—psoriasis	5.41e-05	0.000829	CcSEcCtD
Danazol—Arthralgia—Cyclosporine—psoriasis	5.38e-05	0.000823	CcSEcCtD
Danazol—Anxiety—Cyclosporine—psoriasis	5.36e-05	0.00082	CcSEcCtD
Danazol—Convulsion—Mycophenolate mofetil—psoriasis	5.34e-05	0.000817	CcSEcCtD
Danazol—Hypertension—Mycophenolate mofetil—psoriasis	5.32e-05	0.000815	CcSEcCtD
Danazol—Visual impairment—Dexamethasone—psoriasis	5.31e-05	0.000813	CcSEcCtD
Danazol—Visual impairment—Betamethasone—psoriasis	5.31e-05	0.000813	CcSEcCtD
Danazol—Acute coronary syndrome—Prednisone—psoriasis	5.27e-05	0.000807	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Fluocinonide—psoriasis	5.26e-05	0.0186	CbGdCrCtD
Danazol—CCL2—Spinal Cord Injury—TP53—psoriasis	5.25e-05	0.00136	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—CARM1—psoriasis	5.25e-05	0.00136	CbGpPWpGaD
Danazol—Arthralgia—Mycophenolate mofetil—psoriasis	5.25e-05	0.000803	CcSEcCtD
Danazol—Myocardial infarction—Prednisone—psoriasis	5.24e-05	0.000802	CcSEcCtD
Danazol—Anxiety—Mycophenolate mofetil—psoriasis	5.23e-05	0.0008	CcSEcCtD
Danazol—CCL2—Amcinonide—Clobetasol propionate—psoriasis	5.21e-05	0.0184	CbGdCrCtD
Danazol—GNRHR—Signaling by GPCR—CCL20—psoriasis	5.19e-05	0.00134	CbGpPWpGaD
Danazol—Vertigo—Prednisolone—psoriasis	5.16e-05	0.000791	CcSEcCtD
Danazol—Oedema—Cyclosporine—psoriasis	5.15e-05	0.000789	CcSEcCtD
Danazol—Syncope—Prednisolone—psoriasis	5.15e-05	0.000789	CcSEcCtD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	5.13e-05	0.00133	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TAGAP—psoriasis	5.12e-05	0.00132	CbGpPWpGaD
Danazol—CCL2—Methylprednisolone—Fluocinolone Acetonide—psoriasis	5.11e-05	0.0181	CbGdCrCtD
Danazol—Back pain—Triamcinolone—psoriasis	5.11e-05	0.000783	CcSEcCtD
Danazol—CCL2—Metabolism of proteins—ACE—psoriasis	5.09e-05	0.00132	CbGpPWpGaD
Danazol—Loss of consciousness—Prednisolone—psoriasis	5.05e-05	0.000773	CcSEcCtD
Danazol—Thrombocytopenia—Cyclosporine—psoriasis	5.05e-05	0.000773	CcSEcCtD
Danazol—Vertigo—Hydrocortisone—psoriasis	5.04e-05	0.000772	CcSEcCtD
Danazol—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	5.04e-05	0.0013	CbGpPWpGaD
Danazol—Body temperature increased—Mycophenolic acid—psoriasis	5.04e-05	0.000771	CcSEcCtD
Danazol—Syncope—Hydrocortisone—psoriasis	5.03e-05	0.000771	CcSEcCtD
Danazol—Dizziness—Hydroxyurea—psoriasis	5.03e-05	0.00077	CcSEcCtD
Danazol—Oedema—Mycophenolate mofetil—psoriasis	5.03e-05	0.00077	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5e-05	0.00129	CbGpPWpGaD
Danazol—Hyperhidrosis—Cyclosporine—psoriasis	4.98e-05	0.000763	CcSEcCtD
Danazol—Convulsion—Prednisolone—psoriasis	4.98e-05	0.000762	CcSEcCtD
Danazol—Hypertension—Prednisolone—psoriasis	4.96e-05	0.00076	CcSEcCtD
Danazol—Eosinophilia—Methotrexate—psoriasis	4.96e-05	0.000759	CcSEcCtD
Danazol—Shock—Mycophenolate mofetil—psoriasis	4.95e-05	0.000758	CcSEcCtD
Danazol—Loss of consciousness—Hydrocortisone—psoriasis	4.93e-05	0.000755	CcSEcCtD
Danazol—Thrombocytopenia—Mycophenolate mofetil—psoriasis	4.92e-05	0.000754	CcSEcCtD
Danazol—Pancreatitis—Methotrexate—psoriasis	4.91e-05	0.000752	CcSEcCtD
Danazol—Tachycardia—Mycophenolate mofetil—psoriasis	4.91e-05	0.000751	CcSEcCtD
Danazol—Alopecia—Dexamethasone—psoriasis	4.87e-05	0.000745	CcSEcCtD
Danazol—Alopecia—Betamethasone—psoriasis	4.87e-05	0.000745	CcSEcCtD
Danazol—Convulsion—Hydrocortisone—psoriasis	4.86e-05	0.000745	CcSEcCtD
Danazol—Hyperhidrosis—Mycophenolate mofetil—psoriasis	4.86e-05	0.000744	CcSEcCtD
Danazol—Hypertension—Hydrocortisone—psoriasis	4.85e-05	0.000742	CcSEcCtD
Danazol—ESR1—Regulation of Telomerase—IFNG—psoriasis	4.84e-05	0.00125	CbGpPWpGaD
Danazol—Vomiting—Hydroxyurea—psoriasis	4.84e-05	0.000741	CcSEcCtD
Danazol—Haemoglobin—Prednisone—psoriasis	4.82e-05	0.000738	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—IL6—psoriasis	4.8e-05	0.00124	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.8e-05	0.00124	CbGpPWpGaD
Danazol—Haemorrhage—Prednisone—psoriasis	4.8e-05	0.000735	CcSEcCtD
Danazol—Rash—Hydroxyurea—psoriasis	4.8e-05	0.000734	CcSEcCtD
Danazol—Dermatitis—Hydroxyurea—psoriasis	4.79e-05	0.000734	CcSEcCtD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	4.77e-05	0.00123	CbGpPWpGaD
Danazol—Headache—Hydroxyurea—psoriasis	4.77e-05	0.00073	CcSEcCtD
Danazol—Anxiety—Hydrocortisone—psoriasis	4.76e-05	0.000729	CcSEcCtD
Danazol—Vertigo—Triamcinolone—psoriasis	4.75e-05	0.000727	CcSEcCtD
Danazol—Syncope—Triamcinolone—psoriasis	4.74e-05	0.000726	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—IFNG—psoriasis	4.73e-05	0.00122	CbGpPWpGaD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	4.72e-05	0.00122	CbGpPWpGaD
Danazol—CCL2—Beclomethasone—Fluocinonide—psoriasis	4.72e-05	0.0167	CbGdCrCtD
Danazol—ESR1—Gene Expression—TARS—psoriasis	4.71e-05	0.00122	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	4.7e-05	0.00122	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Cyclosporine—psoriasis	4.7e-05	0.000719	CcSEcCtD
Danazol—Oedema—Prednisolone—psoriasis	4.69e-05	0.000718	CcSEcCtD
Danazol—ESR1—ATF-2 transcription factor network—JUN—psoriasis	4.69e-05	0.00121	CbGpPWpGaD
Danazol—Loss of consciousness—Triamcinolone—psoriasis	4.65e-05	0.000711	CcSEcCtD
Danazol—Paraesthesia—Cyclosporine—psoriasis	4.63e-05	0.000709	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—TYK2—psoriasis	4.63e-05	0.0012	CbGpPWpGaD
Danazol—Shock—Prednisolone—psoriasis	4.61e-05	0.000707	CcSEcCtD
Danazol—CCL2—Beclomethasone—Fluocinolone Acetonide—psoriasis	4.58e-05	0.0162	CbGdCrCtD
Danazol—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	4.58e-05	0.000701	CcSEcCtD
Danazol—Oedema—Hydrocortisone—psoriasis	4.58e-05	0.000701	CcSEcCtD
Danazol—Convulsion—Triamcinolone—psoriasis	4.58e-05	0.000701	CcSEcCtD
Danazol—Tachycardia—Prednisolone—psoriasis	4.58e-05	0.000701	CcSEcCtD
Danazol—Photosensitivity reaction—Methotrexate—psoriasis	4.57e-05	0.0007	CcSEcCtD
Danazol—Asthenia—Mycophenolic acid—psoriasis	4.57e-05	0.0007	CcSEcCtD
Danazol—Hypertension—Triamcinolone—psoriasis	4.56e-05	0.000699	CcSEcCtD
Danazol—Dyspepsia—Cyclosporine—psoriasis	4.54e-05	0.000695	CcSEcCtD
Danazol—Hyperhidrosis—Prednisolone—psoriasis	4.53e-05	0.000694	CcSEcCtD
Danazol—Nausea—Hydroxyurea—psoriasis	4.52e-05	0.000692	CcSEcCtD
Danazol—Paraesthesia—Mycophenolate mofetil—psoriasis	4.51e-05	0.000691	CcSEcCtD
Danazol—Pruritus—Mycophenolic acid—psoriasis	4.51e-05	0.00069	CcSEcCtD
Danazol—Shock—Hydrocortisone—psoriasis	4.51e-05	0.00069	CcSEcCtD
Danazol—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.5e-05	0.00116	CbGpPWpGaD
Danazol—Tachycardia—Hydrocortisone—psoriasis	4.47e-05	0.000685	CcSEcCtD
Danazol—Flushing—Prednisone—psoriasis	4.45e-05	0.000682	CcSEcCtD
Danazol—Fatigue—Cyclosporine—psoriasis	4.44e-05	0.00068	CcSEcCtD
Danazol—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	4.44e-05	0.00115	CbGpPWpGaD
Danazol—Hyperhidrosis—Hydrocortisone—psoriasis	4.43e-05	0.000678	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Methotrexate—psoriasis	4.43e-05	0.000678	CcSEcCtD
Danazol—Dyspepsia—Mycophenolate mofetil—psoriasis	4.43e-05	0.000678	CcSEcCtD
Danazol—Constipation—Cyclosporine—psoriasis	4.41e-05	0.000675	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	4.4e-05	0.00114	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	4.39e-05	0.00114	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—JUN—psoriasis	4.38e-05	0.00113	CbGpPWpGaD
Danazol—CCL2—Fluocinonide—Beclomethasone—psoriasis	4.35e-05	0.0154	CbGdCrCtD
Danazol—Oedema—Triamcinolone—psoriasis	4.31e-05	0.00066	CcSEcCtD
Danazol—Vertigo—Betamethasone—psoriasis	4.31e-05	0.00066	CcSEcCtD
Danazol—Vertigo—Dexamethasone—psoriasis	4.31e-05	0.00066	CcSEcCtD
Danazol—Syncope—Dexamethasone—psoriasis	4.3e-05	0.000659	CcSEcCtD
Danazol—Syncope—Betamethasone—psoriasis	4.3e-05	0.000659	CcSEcCtD
Danazol—Constipation—Mycophenolate mofetil—psoriasis	4.3e-05	0.000658	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.28e-05	0.00111	CbGpPWpGaD
Danazol—Sweating—Methotrexate—psoriasis	4.28e-05	0.000656	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	4.27e-05	0.0011	CbGpPWpGaD
Danazol—Haematuria—Methotrexate—psoriasis	4.26e-05	0.000652	CcSEcCtD
Danazol—Shock—Triamcinolone—psoriasis	4.24e-05	0.00065	CcSEcCtD
Danazol—Alopecia—Prednisone—psoriasis	4.24e-05	0.000649	CcSEcCtD
Danazol—CCL2—Fluocinonide—Fluocinolone Acetonide—psoriasis	4.23e-05	0.0149	CbGdCrCtD
Danazol—Loss of consciousness—Dexamethasone—psoriasis	4.21e-05	0.000645	CcSEcCtD
Danazol—Loss of consciousness—Betamethasone—psoriasis	4.21e-05	0.000645	CcSEcCtD
Danazol—Dizziness—Mycophenolic acid—psoriasis	4.21e-05	0.000645	CcSEcCtD
Danazol—Paraesthesia—Prednisolone—psoriasis	4.21e-05	0.000645	CcSEcCtD
Danazol—Tachycardia—Triamcinolone—psoriasis	4.21e-05	0.000645	CcSEcCtD
Danazol—ESR1—Regulation of Telomerase—JUN—psoriasis	4.18e-05	0.00108	CbGpPWpGaD
Danazol—CCL2—Amcinonide—Beclomethasone—psoriasis	4.17e-05	0.0147	CbGdCrCtD
Danazol—CCL2—Amcinonide—Fluocinonide—psoriasis	4.17e-05	0.0147	CbGdCrCtD
Danazol—Musculoskeletal discomfort—Hydrocortisone—psoriasis	4.17e-05	0.000639	CcSEcCtD
Danazol—Hyperhidrosis—Triamcinolone—psoriasis	4.17e-05	0.000639	CcSEcCtD
Danazol—Convulsion—Betamethasone—psoriasis	4.15e-05	0.000636	CcSEcCtD
Danazol—Convulsion—Dexamethasone—psoriasis	4.15e-05	0.000636	CcSEcCtD
Danazol—Hypertension—Betamethasone—psoriasis	4.14e-05	0.000634	CcSEcCtD
Danazol—Hypertension—Dexamethasone—psoriasis	4.14e-05	0.000634	CcSEcCtD
Danazol—Paraesthesia—Hydrocortisone—psoriasis	4.11e-05	0.00063	CcSEcCtD
Danazol—Urticaria—Cyclosporine—psoriasis	4.09e-05	0.000627	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—JUN—psoriasis	4.09e-05	0.00106	CbGpPWpGaD
Danazol—Body temperature increased—Cyclosporine—psoriasis	4.07e-05	0.000624	CcSEcCtD
Danazol—CCL2—Fluorometholone—Clobetasol propionate—psoriasis	4.07e-05	0.0144	CbGdCrCtD
Danazol—Anxiety—Betamethasone—psoriasis	4.07e-05	0.000623	CcSEcCtD
Danazol—Anxiety—Dexamethasone—psoriasis	4.07e-05	0.000623	CcSEcCtD
Danazol—CCL2—Amcinonide—Fluocinolone Acetonide—psoriasis	4.06e-05	0.0143	CbGdCrCtD
Danazol—Vomiting—Mycophenolic acid—psoriasis	4.05e-05	0.00062	CcSEcCtD
Danazol—Dyspepsia—Hydrocortisone—psoriasis	4.03e-05	0.000617	CcSEcCtD
Danazol—Haemoglobin—Methotrexate—psoriasis	4.03e-05	0.000617	CcSEcCtD
Danazol—ESR1—Regulation of Telomerase—NFKB1—psoriasis	4.03e-05	0.00104	CbGpPWpGaD
Danazol—Rash—Mycophenolic acid—psoriasis	4.02e-05	0.000615	CcSEcCtD
Danazol—Dermatitis—Mycophenolic acid—psoriasis	4.01e-05	0.000615	CcSEcCtD
Danazol—Haemorrhage—Methotrexate—psoriasis	4.01e-05	0.000614	CcSEcCtD
Danazol—AR—Generic Transcription Pathway—CARM1—psoriasis	4e-05	0.00103	CbGpPWpGaD
Danazol—Urticaria—Mycophenolate mofetil—psoriasis	3.99e-05	0.000612	CcSEcCtD
Danazol—Headache—Mycophenolic acid—psoriasis	3.99e-05	0.000611	CcSEcCtD
Danazol—ESR1—LKB1 signaling events—TP53—psoriasis	3.98e-05	0.00103	CbGpPWpGaD
Danazol—Body temperature increased—Mycophenolate mofetil—psoriasis	3.97e-05	0.000609	CcSEcCtD
Danazol—Fatigue—Hydrocortisone—psoriasis	3.95e-05	0.000605	CcSEcCtD
Danazol—Vision blurred—Prednisone—psoriasis	3.94e-05	0.000603	CcSEcCtD
Danazol—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.93e-05	0.000602	CcSEcCtD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.92e-05	0.00101	CbGpPWpGaD
Danazol—Oedema—Betamethasone—psoriasis	3.91e-05	0.000599	CcSEcCtD
Danazol—Oedema—Dexamethasone—psoriasis	3.91e-05	0.000599	CcSEcCtD
Danazol—CYP3A4—Tryptophan metabolism—CAT—psoriasis	3.88e-05	0.001	CbGpPWpGaD
Danazol—Paraesthesia—Triamcinolone—psoriasis	3.87e-05	0.000593	CcSEcCtD
Danazol—Visual impairment—Methotrexate—psoriasis	3.86e-05	0.000592	CcSEcCtD
Danazol—Shock—Dexamethasone—psoriasis	3.85e-05	0.00059	CcSEcCtD
Danazol—Shock—Betamethasone—psoriasis	3.85e-05	0.00059	CcSEcCtD
Danazol—Thrombocytopenia—Betamethasone—psoriasis	3.83e-05	0.000587	CcSEcCtD
Danazol—Thrombocytopenia—Dexamethasone—psoriasis	3.83e-05	0.000587	CcSEcCtD
Danazol—Tachycardia—Betamethasone—psoriasis	3.82e-05	0.000585	CcSEcCtD
Danazol—Tachycardia—Dexamethasone—psoriasis	3.82e-05	0.000585	CcSEcCtD
Danazol—Dyspepsia—Triamcinolone—psoriasis	3.8e-05	0.000581	CcSEcCtD
Danazol—Erythema multiforme—Methotrexate—psoriasis	3.79e-05	0.00058	CcSEcCtD
Danazol—AR—Androgen receptor signaling pathway—STAT3—psoriasis	3.79e-05	0.00098	CbGpPWpGaD
Danazol—Nausea—Mycophenolic acid—psoriasis	3.78e-05	0.00058	CcSEcCtD
Danazol—Hyperhidrosis—Betamethasone—psoriasis	3.78e-05	0.000579	CcSEcCtD
Danazol—Hyperhidrosis—Dexamethasone—psoriasis	3.78e-05	0.000579	CcSEcCtD
Danazol—Vertigo—Prednisone—psoriasis	3.75e-05	0.000575	CcSEcCtD
Danazol—Syncope—Prednisone—psoriasis	3.75e-05	0.000573	CcSEcCtD
Danazol—Urticaria—Prednisolone—psoriasis	3.73e-05	0.000571	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—NFKB1—psoriasis	3.72e-05	0.000963	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HCAR2—psoriasis	3.72e-05	0.000962	CbGpPWpGaD
Danazol—Fatigue—Triamcinolone—psoriasis	3.72e-05	0.000569	CcSEcCtD
Danazol—Asthenia—Cyclosporine—psoriasis	3.7e-05	0.000566	CcSEcCtD
Danazol—Loss of consciousness—Prednisone—psoriasis	3.67e-05	0.000562	CcSEcCtD
Danazol—Pruritus—Cyclosporine—psoriasis	3.65e-05	0.000558	CcSEcCtD
Danazol—Urticaria—Hydrocortisone—psoriasis	3.64e-05	0.000557	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	3.64e-05	0.000941	CbGpPWpGaD
Danazol—Body temperature increased—Hydrocortisone—psoriasis	3.62e-05	0.000555	CcSEcCtD
Danazol—Convulsion—Prednisone—psoriasis	3.62e-05	0.000554	CcSEcCtD
Danazol—Asthenia—Mycophenolate mofetil—psoriasis	3.61e-05	0.000552	CcSEcCtD
Danazol—Hypertension—Prednisone—psoriasis	3.61e-05	0.000552	CcSEcCtD
Danazol—Chills—Methotrexate—psoriasis	3.6e-05	0.000551	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.59e-05	0.000928	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.58e-05	0.000927	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.57e-05	0.000546	CcSEcCtD
Danazol—Musculoskeletal discomfort—Betamethasone—psoriasis	3.57e-05	0.000546	CcSEcCtD
Danazol—Pruritus—Mycophenolate mofetil—psoriasis	3.56e-05	0.000545	CcSEcCtD
Danazol—Arthralgia—Prednisone—psoriasis	3.56e-05	0.000544	CcSEcCtD
Danazol—Anxiety—Prednisone—psoriasis	3.54e-05	0.000543	CcSEcCtD
Danazol—Alopecia—Methotrexate—psoriasis	3.54e-05	0.000543	CcSEcCtD
Danazol—Paraesthesia—Dexamethasone—psoriasis	3.51e-05	0.000538	CcSEcCtD
Danazol—Paraesthesia—Betamethasone—psoriasis	3.51e-05	0.000538	CcSEcCtD
Danazol—Dyspepsia—Betamethasone—psoriasis	3.44e-05	0.000528	CcSEcCtD
Danazol—Dyspepsia—Dexamethasone—psoriasis	3.44e-05	0.000528	CcSEcCtD
Danazol—Urticaria—Triamcinolone—psoriasis	3.43e-05	0.000525	CcSEcCtD
Danazol—Body temperature increased—Triamcinolone—psoriasis	3.41e-05	0.000522	CcSEcCtD
Danazol—Dizziness—Cyclosporine—psoriasis	3.41e-05	0.000522	CcSEcCtD
Danazol—Oedema—Prednisone—psoriasis	3.41e-05	0.000522	CcSEcCtD
Danazol—Back pain—Methotrexate—psoriasis	3.38e-05	0.000517	CcSEcCtD
Danazol—Fatigue—Dexamethasone—psoriasis	3.37e-05	0.000517	CcSEcCtD
Danazol—Fatigue—Betamethasone—psoriasis	3.37e-05	0.000517	CcSEcCtD
Danazol—CCL2—Triamcinolone—Clobetasol propionate—psoriasis	3.36e-05	0.0119	CbGdCrCtD
Danazol—Shock—Prednisone—psoriasis	3.35e-05	0.000513	CcSEcCtD
Danazol—CCL2—Signaling Pathways—CCL20—psoriasis	3.35e-05	0.000867	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.35e-05	0.000866	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—STAT3—psoriasis	3.35e-05	0.000866	CbGpPWpGaD
Danazol—Tachycardia—Prednisone—psoriasis	3.33e-05	0.000509	CcSEcCtD
Danazol—Dizziness—Mycophenolate mofetil—psoriasis	3.32e-05	0.000509	CcSEcCtD
Danazol—Hyperhidrosis—Prednisone—psoriasis	3.29e-05	0.000505	CcSEcCtD
Danazol—Vision blurred—Methotrexate—psoriasis	3.29e-05	0.000504	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.29e-05	0.00085	CbGpPWpGaD
Danazol—Asthenia—Hydrocortisone—psoriasis	3.29e-05	0.000503	CcSEcCtD
Danazol—CCL2—Fluticasone Propionate—Clobetasol propionate—psoriasis	3.28e-05	0.0116	CbGdCrCtD
Danazol—Vomiting—Cyclosporine—psoriasis	3.28e-05	0.000502	CcSEcCtD
Danazol—CCL2—Fluorometholone—Beclomethasone—psoriasis	3.26e-05	0.0115	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Fluocinonide—psoriasis	3.26e-05	0.0115	CbGdCrCtD
Danazol—Rash—Cyclosporine—psoriasis	3.25e-05	0.000498	CcSEcCtD
Danazol—Dermatitis—Cyclosporine—psoriasis	3.25e-05	0.000497	CcSEcCtD
Danazol—CCL2—Flurandrenolide—Fluocinonide—psoriasis	3.24e-05	0.0114	CbGdCrCtD
Danazol—Pruritus—Hydrocortisone—psoriasis	3.24e-05	0.000496	CcSEcCtD
Danazol—Headache—Cyclosporine—psoriasis	3.23e-05	0.000494	CcSEcCtD
Danazol—PGR—Signaling Pathways—TAGAP—psoriasis	3.23e-05	0.000835	CbGpPWpGaD
Danazol—Vomiting—Mycophenolate mofetil—psoriasis	3.2e-05	0.00049	CcSEcCtD
Danazol—CCL2—Desoximetasone—Clobetasol propionate—psoriasis	3.19e-05	0.0113	CbGdCrCtD
Danazol—Rash—Mycophenolate mofetil—psoriasis	3.17e-05	0.000485	CcSEcCtD
Danazol—CCL2—Fluorometholone—Fluocinolone Acetonide—psoriasis	3.17e-05	0.0112	CbGdCrCtD
Danazol—Dermatitis—Mycophenolate mofetil—psoriasis	3.17e-05	0.000485	CcSEcCtD
Danazol—CCL2—Metabolism of proteins—LEP—psoriasis	3.16e-05	0.000817	CbGpPWpGaD
Danazol—CCL2—Flurandrenolide—Fluocinolone Acetonide—psoriasis	3.15e-05	0.0111	CbGdCrCtD
Danazol—Headache—Mycophenolate mofetil—psoriasis	3.15e-05	0.000482	CcSEcCtD
Danazol—Vertigo—Methotrexate—psoriasis	3.14e-05	0.00048	CcSEcCtD
Danazol—PGR—Generic Transcription Pathway—VDR—psoriasis	3.13e-05	0.000811	CbGpPWpGaD
Danazol—Leukopenia—Methotrexate—psoriasis	3.12e-05	0.000478	CcSEcCtD
Danazol—Urticaria—Dexamethasone—psoriasis	3.11e-05	0.000476	CcSEcCtD
Danazol—Urticaria—Betamethasone—psoriasis	3.11e-05	0.000476	CcSEcCtD
Danazol—Musculoskeletal discomfort—Prednisone—psoriasis	3.11e-05	0.000475	CcSEcCtD
Danazol—CYP19A1—Metabolism—NDUFA5—psoriasis	3.1e-05	0.000803	CbGpPWpGaD
Danazol—Dizziness—Prednisolone—psoriasis	3.1e-05	0.000475	CcSEcCtD
Danazol—CCL2—Diflorasone—Clobetasol propionate—psoriasis	3.1e-05	0.0109	CbGdCrCtD
Danazol—Asthenia—Triamcinolone—psoriasis	3.09e-05	0.000474	CcSEcCtD
Danazol—Body temperature increased—Dexamethasone—psoriasis	3.09e-05	0.000474	CcSEcCtD
Danazol—Body temperature increased—Betamethasone—psoriasis	3.09e-05	0.000474	CcSEcCtD
Danazol—ESR1—Generic Transcription Pathway—CARM1—psoriasis	3.08e-05	0.000797	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCL20—psoriasis	3.06e-05	0.000793	CbGpPWpGaD
Danazol—Nausea—Cyclosporine—psoriasis	3.06e-05	0.000469	CcSEcCtD
Danazol—Paraesthesia—Prednisone—psoriasis	3.06e-05	0.000469	CcSEcCtD
Danazol—Pruritus—Triamcinolone—psoriasis	3.05e-05	0.000467	CcSEcCtD
Danazol—Dizziness—Hydrocortisone—psoriasis	3.03e-05	0.000464	CcSEcCtD
Danazol—Convulsion—Methotrexate—psoriasis	3.02e-05	0.000463	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.01e-05	0.000778	CbGpPWpGaD
Danazol—Dyspepsia—Prednisone—psoriasis	3e-05	0.000459	CcSEcCtD
Danazol—Nausea—Mycophenolate mofetil—psoriasis	2.99e-05	0.000457	CcSEcCtD
Danazol—CCL2—GPCR ligand binding—CXCL8—psoriasis	2.98e-05	0.000772	CbGpPWpGaD
Danazol—Arthralgia—Methotrexate—psoriasis	2.97e-05	0.000455	CcSEcCtD
Danazol—Rash—Prednisolone—psoriasis	2.96e-05	0.000453	CcSEcCtD
Danazol—Dermatitis—Prednisolone—psoriasis	2.95e-05	0.000452	CcSEcCtD
Danazol—Fatigue—Prednisone—psoriasis	2.94e-05	0.00045	CcSEcCtD
Danazol—Headache—Prednisolone—psoriasis	2.94e-05	0.00045	CcSEcCtD
Danazol—Constipation—Prednisone—psoriasis	2.91e-05	0.000446	CcSEcCtD
Danazol—Vomiting—Hydrocortisone—psoriasis	2.91e-05	0.000446	CcSEcCtD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.89e-05	0.000748	CbGpPWpGaD
Danazol—Rash—Hydrocortisone—psoriasis	2.89e-05	0.000442	CcSEcCtD
Danazol—Dermatitis—Hydrocortisone—psoriasis	2.89e-05	0.000442	CcSEcCtD
Danazol—Headache—Hydrocortisone—psoriasis	2.87e-05	0.000439	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—JUN—psoriasis	2.87e-05	0.000742	CbGpPWpGaD
Danazol—Dizziness—Triamcinolone—psoriasis	2.85e-05	0.000437	CcSEcCtD
Danazol—ESR1—ATF-2 transcription factor network—IL6—psoriasis	2.83e-05	0.000733	CbGpPWpGaD
Danazol—Asthenia—Betamethasone—psoriasis	2.81e-05	0.00043	CcSEcCtD
Danazol—Asthenia—Dexamethasone—psoriasis	2.81e-05	0.00043	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—JUN—psoriasis	2.79e-05	0.000723	CbGpPWpGaD
Danazol—Thrombocytopenia—Methotrexate—psoriasis	2.79e-05	0.000427	CcSEcCtD
Danazol—Nausea—Prednisolone—psoriasis	2.79e-05	0.000427	CcSEcCtD
Danazol—Pruritus—Betamethasone—psoriasis	2.77e-05	0.000424	CcSEcCtD
Danazol—Pruritus—Dexamethasone—psoriasis	2.77e-05	0.000424	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.76e-05	0.000715	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2.76e-05	0.000714	CbGpPWpGaD
Danazol—CCL2—Clobetasol propionate—Fluocinonide—psoriasis	2.76e-05	0.00974	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Beclomethasone—psoriasis	2.76e-05	0.00974	CbGdCrCtD
Danazol—Hyperhidrosis—Methotrexate—psoriasis	2.75e-05	0.000422	CcSEcCtD
Danazol—Vomiting—Triamcinolone—psoriasis	2.74e-05	0.00042	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—CXCL8—psoriasis	2.73e-05	0.000706	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Fluocinonide—psoriasis	2.72e-05	0.00961	CbGdCrCtD
Danazol—Nausea—Hydrocortisone—psoriasis	2.72e-05	0.000417	CcSEcCtD
Danazol—Rash—Triamcinolone—psoriasis	2.72e-05	0.000416	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.72e-05	0.000703	CbGpPWpGaD
Danazol—CCL2—Budesonide—Clobetasol propionate—psoriasis	2.72e-05	0.0096	CbGdCrCtD
Danazol—Dermatitis—Triamcinolone—psoriasis	2.72e-05	0.000416	CcSEcCtD
Danazol—ESR1—Signaling by ERBB4—TYK2—psoriasis	2.72e-05	0.000703	CbGpPWpGaD
Danazol—Urticaria—Prednisone—psoriasis	2.71e-05	0.000415	CcSEcCtD
Danazol—Headache—Triamcinolone—psoriasis	2.7e-05	0.000414	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—TP53—psoriasis	2.7e-05	0.000698	CbGpPWpGaD
Danazol—Body temperature increased—Prednisone—psoriasis	2.69e-05	0.000413	CcSEcCtD
Danazol—CCL2—Triamcinolone—Fluocinonide—psoriasis	2.69e-05	0.00951	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Beclomethasone—psoriasis	2.69e-05	0.00951	CbGdCrCtD
Danazol—AR—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.69e-05	0.000696	CbGpPWpGaD
Danazol—CCL2—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	2.68e-05	0.00946	CbGdCrCtD
Danazol—CCL2—Flunisolide—Fluocinolone Acetonide—psoriasis	2.65e-05	0.00934	CbGdCrCtD
Danazol—CYP19A1—Metabolism—CYP2S1—psoriasis	2.64e-05	0.000682	CbGpPWpGaD
Danazol—CCL2—Fluticasone Propionate—Beclomethasone—psoriasis	2.63e-05	0.00928	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Fluocinonide—psoriasis	2.63e-05	0.00928	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Fluocinolone Acetonide—psoriasis	2.62e-05	0.00925	CbGdCrCtD
Danazol—Musculoskeletal discomfort—Methotrexate—psoriasis	2.6e-05	0.000397	CcSEcCtD
Danazol—Dizziness—Dexamethasone—psoriasis	2.59e-05	0.000396	CcSEcCtD
Danazol—Dizziness—Betamethasone—psoriasis	2.59e-05	0.000396	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Hydrocortisone—psoriasis	2.58e-05	0.00912	CbGdCrCtD
Danazol—Nausea—Triamcinolone—psoriasis	2.56e-05	0.000392	CcSEcCtD
Danazol—CCL2—Desoximetasone—Beclomethasone—psoriasis	2.56e-05	0.00903	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Fluocinonide—psoriasis	2.56e-05	0.00903	CbGdCrCtD
Danazol—Paraesthesia—Methotrexate—psoriasis	2.56e-05	0.000392	CcSEcCtD
Danazol—CCL2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	2.55e-05	0.00902	CbGdCrCtD
Danazol—PGR—Gene Expression—CARM1—psoriasis	2.53e-05	0.000654	CbGpPWpGaD
Danazol—Dyspepsia—Methotrexate—psoriasis	2.51e-05	0.000384	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	2.51e-05	0.000648	CbGpPWpGaD
Danazol—Vomiting—Betamethasone—psoriasis	2.49e-05	0.000381	CcSEcCtD
Danazol—Vomiting—Dexamethasone—psoriasis	2.49e-05	0.000381	CcSEcCtD
Danazol—CCL2—Desoximetasone—Fluocinolone Acetonide—psoriasis	2.49e-05	0.00878	CbGdCrCtD
Danazol—CCL2—Diflorasone—Beclomethasone—psoriasis	2.48e-05	0.00877	CbGdCrCtD
Danazol—CCL2—Diflorasone—Fluocinonide—psoriasis	2.48e-05	0.00877	CbGdCrCtD
Danazol—ESR1—AP-1 transcription factor network—IL6—psoriasis	2.47e-05	0.000639	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	2.47e-05	0.000639	CbGpPWpGaD
Danazol—Rash—Betamethasone—psoriasis	2.47e-05	0.000378	CcSEcCtD
Danazol—Rash—Dexamethasone—psoriasis	2.47e-05	0.000378	CcSEcCtD
Danazol—Dermatitis—Betamethasone—psoriasis	2.47e-05	0.000378	CcSEcCtD
Danazol—Dermatitis—Dexamethasone—psoriasis	2.47e-05	0.000378	CcSEcCtD
Danazol—Fatigue—Methotrexate—psoriasis	2.46e-05	0.000376	CcSEcCtD
Danazol—Headache—Betamethasone—psoriasis	2.45e-05	0.000375	CcSEcCtD
Danazol—Headache—Dexamethasone—psoriasis	2.45e-05	0.000375	CcSEcCtD
Danazol—Asthenia—Prednisone—psoriasis	2.45e-05	0.000374	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.44e-05	0.000632	CbGpPWpGaD
Danazol—CCL2—Diflorasone—Fluocinolone Acetonide—psoriasis	2.41e-05	0.00852	CbGdCrCtD
Danazol—Pruritus—Prednisone—psoriasis	2.41e-05	0.000369	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Betamethasone—psoriasis	2.4e-05	0.00847	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Dexamethasone—psoriasis	2.4e-05	0.00847	CbGdCrCtD
Danazol—AR—Generic Transcription Pathway—VDR—psoriasis	2.39e-05	0.000618	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.38e-05	0.000615	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2.38e-05	0.000615	CbGpPWpGaD
Danazol—CCL2—Methylprednisolone—Triamcinolone—psoriasis	2.34e-05	0.00827	CbGdCrCtD
Danazol—Nausea—Dexamethasone—psoriasis	2.32e-05	0.000356	CcSEcCtD
Danazol—Nausea—Betamethasone—psoriasis	2.32e-05	0.000356	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.29e-05	0.000592	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—psoriasis	2.26e-05	0.000585	CbGpPWpGaD
Danazol—Urticaria—Methotrexate—psoriasis	2.26e-05	0.000347	CcSEcCtD
Danazol—Dizziness—Prednisone—psoriasis	2.25e-05	0.000345	CcSEcCtD
Danazol—Body temperature increased—Methotrexate—psoriasis	2.25e-05	0.000345	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Prednisone—psoriasis	2.22e-05	0.00785	CbGdCrCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	2.21e-05	0.000572	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—PPARG—psoriasis	2.19e-05	0.000565	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HCAR2—psoriasis	2.18e-05	0.000565	CbGpPWpGaD
Danazol—CCL2—Budesonide—Beclomethasone—psoriasis	2.18e-05	0.00769	CbGdCrCtD
Danazol—CCL2—Budesonide—Fluocinonide—psoriasis	2.18e-05	0.00769	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Prednisolone—psoriasis	2.17e-05	0.00766	CbGdCrCtD
Danazol—Vomiting—Prednisone—psoriasis	2.17e-05	0.000332	CcSEcCtD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	2.16e-05	0.000558	CbGpPWpGaD
Danazol—CCL2—Beclomethasone—Betamethasone—psoriasis	2.15e-05	0.00759	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Dexamethasone—psoriasis	2.15e-05	0.00759	CbGdCrCtD
Danazol—Rash—Prednisone—psoriasis	2.15e-05	0.000329	CcSEcCtD
Danazol—Dermatitis—Prednisone—psoriasis	2.15e-05	0.000329	CcSEcCtD
Danazol—Headache—Prednisone—psoriasis	2.14e-05	0.000327	CcSEcCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2.13e-05	0.00055	CbGpPWpGaD
Danazol—CCL2—Budesonide—Fluocinolone Acetonide—psoriasis	2.12e-05	0.00747	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Triamcinolone—psoriasis	2.1e-05	0.00742	CbGdCrCtD
Danazol—CCL2—Metabolism of proteins—CXCL8—psoriasis	2.1e-05	0.000543	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—psoriasis	2.09e-05	0.000541	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.08e-05	0.000537	CbGpPWpGaD
Danazol—Asthenia—Methotrexate—psoriasis	2.04e-05	0.000313	CcSEcCtD
Danazol—Nausea—Prednisone—psoriasis	2.02e-05	0.00031	CcSEcCtD
Danazol—Pruritus—Methotrexate—psoriasis	2.02e-05	0.000309	CcSEcCtD
Danazol—CCL2—Fluocinonide—Betamethasone—psoriasis	1.98e-05	0.00701	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Dexamethasone—psoriasis	1.98e-05	0.00701	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Prednisolone—psoriasis	1.95e-05	0.00687	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Triamcinolone—psoriasis	1.94e-05	0.00685	CbGdCrCtD
Danazol—PGR—Signaling Pathways—CCL20—psoriasis	1.93e-05	0.0005	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.93e-05	0.000499	CbGpPWpGaD
Danazol—AR—Gene Expression—CARM1—psoriasis	1.93e-05	0.000498	CbGpPWpGaD
Danazol—CCL2—Amcinonide—Dexamethasone—psoriasis	1.9e-05	0.00672	CbGdCrCtD
Danazol—CCL2—Amcinonide—Betamethasone—psoriasis	1.9e-05	0.00672	CbGdCrCtD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—psoriasis	1.89e-05	0.00049	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TAGAP—psoriasis	1.89e-05	0.00049	CbGpPWpGaD
Danazol—Dizziness—Methotrexate—psoriasis	1.88e-05	0.000288	CcSEcCtD
Danazol—CCL2—Amcinonide—Triamcinolone—psoriasis	1.86e-05	0.00656	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—SOCS1—psoriasis	1.84e-05	0.000477	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—VDR—psoriasis	1.84e-05	0.000476	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.83e-05	0.000474	CbGpPWpGaD
Danazol—Vomiting—Methotrexate—psoriasis	1.81e-05	0.000277	CcSEcCtD
Danazol—Rash—Methotrexate—psoriasis	1.8e-05	0.000275	CcSEcCtD
Danazol—Dermatitis—Methotrexate—psoriasis	1.79e-05	0.000275	CcSEcCtD
Danazol—Headache—Methotrexate—psoriasis	1.78e-05	0.000273	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.78e-05	0.00046	CbGpPWpGaD
Danazol—CCL2—Amcinonide—Prednisone—psoriasis	1.76e-05	0.00623	CbGdCrCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.76e-05	0.000456	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—TYK2—psoriasis	1.76e-05	0.000455	CbGpPWpGaD
Danazol—CCL2—Amcinonide—Prednisolone—psoriasis	1.72e-05	0.00608	CbGdCrCtD
Danazol—Nausea—Methotrexate—psoriasis	1.69e-05	0.000259	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—IL6—psoriasis	1.69e-05	0.000437	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SOCS1—psoriasis	1.69e-05	0.000437	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—PPARG—psoriasis	1.66e-05	0.000431	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Clobetasol propionate—psoriasis	1.66e-05	0.00587	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Clobetasol propionate—psoriasis	1.66e-05	0.00587	CbGdCrCtD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.63e-05	0.000422	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—TYK2—psoriasis	1.61e-05	0.000416	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Hydrocortisone—psoriasis	1.6e-05	0.00565	CbGdCrCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.6e-05	0.000414	CbGpPWpGaD
Danazol—CCL2—Flurandrenolide—Hydrocortisone—psoriasis	1.59e-05	0.00562	CbGdCrCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.57e-05	0.000406	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CXCL8—psoriasis	1.54e-05	0.000399	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCL8—psoriasis	1.53e-05	0.000396	CbGpPWpGaD
Danazol—PGR—Gene Expression—VDR—psoriasis	1.51e-05	0.00039	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Betamethasone—psoriasis	1.49e-05	0.00525	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Dexamethasone—psoriasis	1.49e-05	0.00525	CbGdCrCtD
Danazol—ESR1—Gene Expression—CARM1—psoriasis	1.48e-05	0.000384	CbGpPWpGaD
Danazol—CCL2—Flurandrenolide—Dexamethasone—psoriasis	1.48e-05	0.00522	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Betamethasone—psoriasis	1.48e-05	0.00522	CbGdCrCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.46e-05	0.000377	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Triamcinolone—psoriasis	1.45e-05	0.00513	CbGdCrCtD
Danazol—GNRHR—Signaling by GPCR—CXCL8—psoriasis	1.4e-05	0.000362	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.38e-05	0.000358	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Prednisone—psoriasis	1.38e-05	0.00487	CbGdCrCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.37e-05	0.000355	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LEP—psoriasis	1.36e-05	0.000352	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—psoriasis	1.36e-05	0.000352	CbGpPWpGaD
Danazol—CCL2—Fluorometholone—Prednisolone—psoriasis	1.35e-05	0.00475	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Prednisolone—psoriasis	1.34e-05	0.00472	CbGdCrCtD
Danazol—CCL2—Flunisolide—Hydrocortisone—psoriasis	1.34e-05	0.00472	CbGdCrCtD
Danazol—CCL2—Betamethasone—Fluocinonide—psoriasis	1.33e-05	0.0047	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Beclomethasone—psoriasis	1.33e-05	0.0047	CbGdCrCtD
Danazol—CCL2—Betamethasone—Beclomethasone—psoriasis	1.33e-05	0.0047	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Fluocinonide—psoriasis	1.33e-05	0.0047	CbGdCrCtD
Danazol—ESR1—Signaling by ERBB4—IL6—psoriasis	1.33e-05	0.000344	CbGpPWpGaD
Danazol—CCL2—Triamcinolone—Hydrocortisone—psoriasis	1.32e-05	0.00467	CbGdCrCtD
Danazol—CCL2—Betamethasone—Fluocinolone Acetonide—psoriasis	1.29e-05	0.00457	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Fluocinolone Acetonide—psoriasis	1.29e-05	0.00457	CbGdCrCtD
Danazol—CYP19A1—Metabolism—CARM1—psoriasis	1.29e-05	0.000333	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PPARG—psoriasis	1.28e-05	0.000332	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NFKBIA—psoriasis	1.27e-05	0.000328	CbGpPWpGaD
Danazol—CCL2—Clobetasol propionate—Betamethasone—psoriasis	1.26e-05	0.00444	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Dexamethasone—psoriasis	1.26e-05	0.00444	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Hydrocortisone—psoriasis	1.26e-05	0.00443	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—APOE—psoriasis	1.25e-05	0.000322	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LEP—psoriasis	1.25e-05	0.000322	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Dexamethasone—psoriasis	1.24e-05	0.00438	CbGdCrCtD
Danazol—CCL2—Flunisolide—Betamethasone—psoriasis	1.24e-05	0.00438	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Triamcinolone—psoriasis	1.23e-05	0.00434	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Dexamethasone—psoriasis	1.23e-05	0.00434	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Betamethasone—psoriasis	1.23e-05	0.00434	CbGdCrCtD
Danazol—CCL2—Flunisolide—Triamcinolone—psoriasis	1.21e-05	0.00428	CbGdCrCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.21e-05	0.000313	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.2e-05	0.000312	CbGpPWpGaD
Danazol—CCL2—Fluticasone Propionate—Dexamethasone—psoriasis	1.2e-05	0.00423	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Betamethasone—psoriasis	1.2e-05	0.00423	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Triamcinolone—psoriasis	1.17e-05	0.00413	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Betamethasone—psoriasis	1.17e-05	0.00412	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Dexamethasone—psoriasis	1.17e-05	0.00412	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisone—psoriasis	1.17e-05	0.00412	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—NFKBIA—psoriasis	1.16e-05	0.0003	CbGpPWpGaD
Danazol—CCL2—Flunisolide—Prednisone—psoriasis	1.15e-05	0.00406	CbGdCrCtD
Danazol—AR—Gene Expression—VDR—psoriasis	1.15e-05	0.000297	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Triamcinolone—psoriasis	1.14e-05	0.00402	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisone—psoriasis	1.14e-05	0.00402	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisolone—psoriasis	1.14e-05	0.00402	CbGdCrCtD
Danazol—ESR1—Signaling Pathways—CCL20—psoriasis	1.13e-05	0.000293	CbGpPWpGaD
Danazol—CCL2—Diflorasone—Dexamethasone—psoriasis	1.13e-05	0.004	CbGdCrCtD
Danazol—CCL2—Diflorasone—Betamethasone—psoriasis	1.13e-05	0.004	CbGdCrCtD
Danazol—CCL2—Flunisolide—Prednisolone—psoriasis	1.12e-05	0.00397	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisolone—psoriasis	1.11e-05	0.00392	CbGdCrCtD
Danazol—CCL2—Diflorasone—Triamcinolone—psoriasis	1.11e-05	0.0039	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Prednisone—psoriasis	1.08e-05	0.00382	CbGdCrCtD
Danazol—CCL2—Budesonide—Hydrocortisone—psoriasis	1.07e-05	0.00377	CbGdCrCtD
Danazol—PGR—Signaling Pathways—SOCS1—psoriasis	1.06e-05	0.000275	CbGpPWpGaD
Danazol—CCL2—Desoximetasone—Prednisolone—psoriasis	1.06e-05	0.00373	CbGdCrCtD
Danazol—PGR—Gene Expression—PPARG—psoriasis	1.05e-05	0.000272	CbGpPWpGaD
Danazol—CCL2—Diflorasone—Prednisone—psoriasis	1.05e-05	0.00371	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—TYK2—psoriasis	1.04e-05	0.000269	CbGpPWpGaD
Danazol—CCL2—Diflorasone—Prednisolone—psoriasis	1.02e-05	0.00362	CbGdCrCtD
Danazol—CCL2—Budesonide—Betamethasone—psoriasis	9.92e-06	0.0035	CbGdCrCtD
Danazol—CCL2—Budesonide—Dexamethasone—psoriasis	9.92e-06	0.0035	CbGdCrCtD
Danazol—CCL2—Budesonide—Triamcinolone—psoriasis	9.69e-06	0.00342	CbGdCrCtD
Danazol—GNRHR—Signaling Pathways—TYK2—psoriasis	9.5e-06	0.000246	CbGpPWpGaD
Danazol—CCL2—Budesonide—Prednisone—psoriasis	9.2e-06	0.00325	CbGdCrCtD
Danazol—CYP3A4—Metabolism—NDUFA5—psoriasis	9.05e-06	0.000234	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL8—psoriasis	9.05e-06	0.000234	CbGpPWpGaD
Danazol—CCL2—Budesonide—Prednisolone—psoriasis	8.98e-06	0.00317	CbGdCrCtD
Danazol—ESR1—Gene Expression—VDR—psoriasis	8.86e-06	0.000229	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—psoriasis	8.6e-06	0.000223	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—JUN—psoriasis	8.41e-06	0.000218	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL8—psoriasis	8.28e-06	0.000214	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NFKB1—psoriasis	8.1e-06	0.000209	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARG—psoriasis	8.01e-06	0.000207	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAT—psoriasis	7.92e-06	0.000205	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—psoriasis	7.87e-06	0.000204	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—psoriasis	7.85e-06	0.000203	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—psoriasis	7.85e-06	0.000203	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2S1—psoriasis	7.7e-06	0.000199	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—JUN—psoriasis	7.69e-06	0.000199	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NFKB1—psoriasis	7.41e-06	0.000192	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—psoriasis	7.35e-06	0.00019	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFKBIA—psoriasis	7.32e-06	0.000189	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—psoriasis	7.28e-06	0.000188	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—psoriasis	6.72e-06	0.000174	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—psoriasis	6.65e-06	0.000172	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Hydrocortisone—psoriasis	6.54e-06	0.00231	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Hydrocortisone—psoriasis	6.54e-06	0.00231	CbGdCrCtD
Danazol—ESR1—Signaling Pathways—SOCS1—psoriasis	6.25e-06	0.000162	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—psoriasis	6.17e-06	0.00016	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—psoriasis	6.16e-06	0.000159	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Dexamethasone—psoriasis	6.07e-06	0.00214	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Betamethasone—psoriasis	6.07e-06	0.00214	CbGdCrCtD
Danazol—PGR—Signaling Pathways—TYK2—psoriasis	5.99e-06	0.000155	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Triamcinolone—psoriasis	5.93e-06	0.00209	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Triamcinolone—psoriasis	5.93e-06	0.00209	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Prednisone—psoriasis	5.63e-06	0.00199	CbGdCrCtD
Danazol—CCL2—Betamethasone—Prednisone—psoriasis	5.63e-06	0.00199	CbGdCrCtD
Danazol—CCL2—Signaling Pathways—TP53—psoriasis	5.55e-06	0.000144	CbGpPWpGaD
Danazol—CCL2—Betamethasone—Prednisolone—psoriasis	5.49e-06	0.00194	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Prednisolone—psoriasis	5.49e-06	0.00194	CbGdCrCtD
Danazol—CYP19A1—Metabolism—PPARG—psoriasis	5.36e-06	0.000139	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL8—psoriasis	5.22e-06	0.000135	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—psoriasis	5.08e-06	0.000131	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—psoriasis	5.08e-06	0.000131	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUN—psoriasis	4.85e-06	0.000126	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFKB1—psoriasis	4.67e-06	0.000121	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—psoriasis	4.65e-06	0.00012	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—psoriasis	4.61e-06	0.000119	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—psoriasis	4.61e-06	0.000119	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFKBIA—psoriasis	4.29e-06	0.000111	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—psoriasis	4.24e-06	0.00011	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—psoriasis	4.2e-06	0.000109	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CARM1—psoriasis	3.76e-06	9.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TYK2—psoriasis	3.52e-06	9.1e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—psoriasis	3.2e-06	8.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL8—psoriasis	3.06e-06	7.92e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—psoriasis	2.93e-06	7.58e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUN—psoriasis	2.85e-06	7.37e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFKB1—psoriasis	2.74e-06	7.09e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—psoriasis	2.49e-06	6.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—psoriasis	2.46e-06	6.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAT—psoriasis	2.31e-06	5.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—psoriasis	1.88e-06	4.86e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—psoriasis	1.8e-06	4.65e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—psoriasis	1.72e-06	4.45e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—psoriasis	1.56e-06	4.05e-05	CbGpPWpGaD
